ALBUQUERQUE (Azat TV) – A veteran Drug Enforcement Administration agent has alleged that the federal agency permitted millions of illicit fentanyl pills to flood New Mexico streets through a controversial investigative practice known as “fentanyl walking,” according to CBS News. The disclosures have intensified scrutiny on federal law enforcement operations as state officials grapple with a soaring overdose crisis.
Active-duty DEA Special Agent David Howell stated in an interview that for three years his managers ignored internal warnings regarding dangerous quantities of the synthetic opioid reaching communities. The investigative method involves allowing suspected drug traffickers to distribute contraband while federal agents track the supply chain to build larger conspiracy cases. Because fentanyl is exceptionally lethal, Howell argued the strategy creates unacceptable public safety hazards.
The Albuquerque Interception and Internal Clash
During a 2023 operation in Albuquerque, Howell and his tactical team monitored a suspect from the air who picked up a child and drove away in a white SUV, as documented by CBS News using congressional records from the House Oversight Committee. Agents in a secondary vehicle intercepted the vehicle, secured the child, and detained the driver. Authorities recovered a firearm and between 6,000 and 7,000 fentanyl pills concealed beneath the child’s seat.
Instead of receiving commendation, Howell asserted that prosecutors from the U.S. Attorney’s Office for the District of New Mexico chastised the agents for seizing the contraband, indicating a willingness to let the shipment reach its destination despite the presence of a child. Howell’s initial whistleblower disclosures were first reported in June by the Associated Press and the Albuquerque Journal.
Retaliation Complaints and State Legal Action
The controversy widened when a second former DEA employee filed a formal retaliation complaint through the nonprofit Empower Oversight, detailed in an Albuquerque Journal report. Kevin Small, a retired 31-year DEA veteran working as a contractor in Albuquerque, alleged he faced severe professional hostility after supporting Howell. Small stated that during a 2024 wiretap investigation, agents tracked a shipment of 350,000 fentanyl pills heading to Albuquerque but were instructed not to intercept it.
According to the complaint filed by Fairfax, Virginia-based Empower Oversight, Small confronted a tense meeting with Assistant Special Agent in Charge Jeffrey Armijo, who allegedly threatened an investigation and restricted Small’s work hours before forcing his resignation, effective August 31, 2024. The filing notes that Department of Justice internal policy mandates reasonable efforts to mitigate public safety risks during wiretaps, even if interdiction compromises an ongoing investigation.
The revelations prompted New Mexico Attorney General Raúl Torrez to file a lawsuit against the federal government over the practice. Torrez stated that the state’s deteriorating public safety metrics directly correlate with the federal strategy of walking fentanyl. Local officials across the Albuquerque metropolitan area have declared states of emergency due to unprecedented spikes in fatal overdose calls.
Federal Response and Next Procedural Steps
While the Department of Justice and the DEA declined direct television interview requests from CBS News, the DOJ issued a formal statement confirming that DEA Administrator Cole requested an independent investigation by the DOJ Office of Inspector General immediately upon receiving the whistleblower disclosures. That inspector general inquiry remains active, and agency officials have indicated that recommended operational improvements will be implemented once the review concludes.

